CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 05, 2026 16:00 HKT |  |
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Feb 25, 2026 19:57 HKT |  |
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT | |
|
Modern Dental Group Celebrates 40 Years: 'Redefining Smiles. The Digital Way.'
Feb 13, 2026 10:31 HKT |  |
|
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
Feb 11, 2026 19:00 HKT |  |
|
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
Feb 02, 2026 20:00 HKT | |
|
REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio
Jan 31, 2026 02:40 HKT |  |
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 21:30 HKT | |
|
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
Jan 29, 2026 20:57 HKT | |
|
Hong Kong Tech Firms Win Big at CES 2026 with Frontier Tech Innovations to Draw Global Buyer Interest
Jan 08, 2026 19:31 HKT |  |
|
Avantor Appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle East & Africa
Dec 24, 2025 12:20 HKT |  |
|
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
Dec 15, 2025 21:00 HKT |  |
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT | |
|
AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation
Dec 02, 2025 12:22 HKT |  |
|
'iRad Hospital' and 'Hong Kong Sanatorium & Hospital' Partner to Launch Premium Cross-Border Medical Concierge Services
Nov 17, 2025 16:54 HKT | |
|
Cornerstone Robotics Closes Oversubscribed New Financing Round of Approximately US$200 million
Nov 11, 2025 11:38 HKT |  |
|
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 20:00 HKT | |
|
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R)
Oct 27, 2025 22:00 HKT | |
|
Kangji Medical and Knight Bidco Jointly Dispatch Scheme Document for Privatisation Proposal
Oct 13, 2025 10:14 HKT | |
|
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
Sep 28, 2025 15:00 HKT | |
|